This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
NAT-OMEPRAZOLE DR
NATCO PHARMA (CANADA) INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is NAT-OMEPRAZOLE DR discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that NAT-OMEPRAZOLE DR 20MG has been permanently discontinued (last updated December 6, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is NAT-OMEPRAZOLE DR not available?
The reason the manufacturer reported: Business reasons.
Proton Pump Inhibitor (PPI) Shortage in Canada: Omeprazole, Pantoprazole, Rabeprazole
Why a shortage of one PPI brand rarely means the whole class is unavailable, when a pharmacist can swap manufacturers, and when it needs your prescriber.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
NOVO-OMEPRAZOLE
TEVA CANADA LIMITED
ESOMEPRAZOLE
SIVEM PHARMACEUTICALS ULC
RATIO-OMEPRAZOLE
TEVA CANADA LIMITED
Other Products
LOSEC
CHEPLAPHARM ARZNEIMITTEL GMBH
Q-OMEPRAZOLE
QD PHARMACEUTICALS ULC
AURO-OMEPRAZOLE
AURO PHARMA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-06-30
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02439549
Strength
20MG
Dosage Form
TABLET (DELAYED-RELEASE)
Route
ORAL
Active Ingredient
OMEPRAZOLE
Tier
Unrated
Last Updated
2025-07-03
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
NAT-OMEPRAZOLE DR has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from NATCO PHARMA (CANADA) INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
250MG · DIN 02494132
1MG · DIN 02417855
2.5MG · DIN 02492814
5MG · DIN 02492822
100MG · DIN 02496895
25MG · DIN 02496887
62.5MG · DIN 02467984
125MG · DIN 02467992
20MG · DIN 02496488
10MG · DIN 02496461
40MG · DIN 02409038
20MG · DIN 02409011